Cervilla Jorge A, Rivera Margarita, Molina Esther, Torres-González Francisco, Bellón Juan A, Moreno Berta, de Dios Luna Juan, Lorente José A, de Diego-Otero Yolanda, King Michael, Nazareth Irwin, Gutiérrez Blanca
Departamento de Medicina Legal, Toxicología y Psiquiatría, Facultad de Medicina, Universidad de Granada, Granada, Spain.
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):912-7. doi: 10.1002/ajmg.b.30455.
Previous reports and meta-analyses have yielded inconclusive results as to whether the s/s genotype at the 5-HTTLPR serotonin transporter polymorphism confers increased risk for depression. We tested the association between s/s genotype and depression in a large cohort (n = 737) of Spanish primary care consecutive attendees participating in a European study on predictors for depression in primary care (PREDICT study). Participants were administered the Composite International Diagnostic Interview (CIDI) depression subscale allowing diagnoses using ICD-10 criteria for depressive episodes. Participants were genotyped to establish 5HTTLPR genotype. Both univariable and multivariable associations between the s/s genotype and depression were tested twice using two different depressive outcomes (ICD-10 depressive episode and ICD-10 severe depressive episode). We found an association between the s/s genotype and both depressive outcomes that was independent of age, sex, family history of psychological problems among first degree relatives and presence of comorbid generalized anxiety disorder. When comparing s/s homozygous versus the rest, the adjusted odds ratio for any ICD-10 depressive episode and for severe ICD-10 depressive episode were 1.50 (95% CI: 1.0-2.2; P = 0.045) and 1.79 (95% CI: 1.1-2.8; P = 0.016), respectively. The association was significantly stronger with increasing severity of depression (chi2 for linear association=6.1; P = 0.013) suggesting a dose-dependent relationship. Our results are consistent with previous reports suggesting a small but independent effect by the s/s 5-HTTLPR genotype increasing the risk for depression.
先前的报告和荟萃分析对于5-羟色胺转运体基因多态性(5-HTTLPR)的s/s基因型是否会增加患抑郁症的风险得出了不确定的结果。我们在一个大型队列(n = 737)中测试了s/s基因型与抑郁症之间的关联,该队列由参与一项欧洲初级保健抑郁症预测因素研究(PREDICT研究)的西班牙初级保健连续就诊者组成。对参与者进行了综合国际诊断访谈(CIDI)抑郁症分量表的测试,允许根据国际疾病分类第10版(ICD-10)标准对抑郁发作进行诊断。对参与者进行基因分型以确定5HTTLPR基因型。使用两种不同的抑郁结局(ICD-10抑郁发作和ICD-10重度抑郁发作)对s/s基因型与抑郁症之间的单变量和多变量关联进行了两次测试。我们发现s/s基因型与两种抑郁结局之间存在关联,且该关联独立于年龄、性别、一级亲属中的心理问题家族史以及共病广泛性焦虑症的存在。当比较s/s纯合子与其他基因型时,任何ICD-10抑郁发作和重度ICD-10抑郁发作的调整优势比分别为1.50(95%置信区间:1.0 - 2.2;P = 0.045)和1.79(95%置信区间:1.1 - 2.8;P = 0.016)。随着抑郁症严重程度的增加,这种关联显著更强(线性关联的卡方值=6.1;P = 0.013),表明存在剂量依赖关系。我们的结果与先前的报告一致,表明s/s 5-HTTLPR基因型有一个小但独立的效应,会增加患抑郁症的风险。